Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 85201-85250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05689970
ST-segment Elevation Not Associated With Acute Cardiac Necrosis (LESTONNAC)
N/AActive, not recruiting
420 participants
Started: Jul 25, 2022 · Completed: Jul 24, 2024
1 condition3 sponsors7 locations
NCT05442710
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
PHASE2Recruiting
142 participants
Started: Jul 24, 2022 · Completed: Jun 30, 2026
1 condition3 sponsors20 locations
NCT05492240
Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities
NARecruiting
2,880 participants
Started: Jul 24, 2022 · Completed: Jun 30, 2026
5 conditions3 sponsors2 locations
NCT06036225
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
NARecruiting
20 participants
Started: Jul 24, 2022 · Completed: Sep 27, 2024
1 condition2 sponsors1 location
NCT04308759
An Innovative Conversational Agent (Quitbot) for Smoking Cessation
PHASE3Active, not recruiting
1,647 participants
Started: Jul 24, 2022 · Completed: May 1, 2026
1 condition2 sponsors1 location
NCT06569134
Identification of Neuroprognostic Factors for Out-of-hospital Cardiopulmonary Arrest (MIRA29)
N/AActive, not recruiting
1,200 participants
Started: Jul 24, 2022 · Completed: Jan 24, 2025
3 conditions1 sponsor2 locations
NCT05497180
Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea
PHASE1Recruiting
40 participants
Started: Jul 23, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05467813
Mirror Therapy Preceding Augmented Reality in Stroke Rehabilitation
NARecruiting
50 participants
Started: Jul 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05286151
Network Connectivity and Temporal Processing in Adolescents Who Stutter
NARecruiting
500 participants
Started: Jul 23, 2022 · Completed: Jan 31, 2027
2 conditions2 sponsors1 location
NCT05767424
Prospective Observational Study for Breast Microcalcifications' Classification With Artificial Intelligence Techniques
N/AActive, not recruiting
1,426 participants
Started: Jul 22, 2022 · Completed: Jul 25, 2028
2 conditions1 sponsor1 location
NCT05501353
Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods
N/ARecruiting
125 participants
Started: Jul 22, 2022 · Completed: Sep 1, 2027
1 condition3 sponsors1 location
NCT04968405
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
NARecruiting
90 participants
Started: Jul 22, 2022 · Completed: Feb 28, 2026
3 conditions1 sponsor3 locations
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
PHASE4Recruiting
1,656 participants
Started: Jul 22, 2022 · Completed: Aug 1, 2028
2 conditions2 sponsors26 locations
NCT05411198
Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma
PHASE3Recruiting
65 participants
Started: Jul 22, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor25 locations
NCT05430581
Prediction of Knee Injuries Through System Dynamics Modeling
N/AActive, not recruiting
99 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05521789
Erector Spinae Block for Thoracic Surgery
PHASE4Recruiting
70 participants
Started: Jul 22, 2022 · Completed: Jul 21, 2026
5 conditions1 sponsor1 location
NCT05321420
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
PHASE2Active, not recruiting
240 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor103 locations
NCT05254743
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
PHASE3Recruiting
662 participants
Started: Jul 22, 2022 · Completed: Jan 31, 2028
4 conditions1 sponsor148 locations
NCT05153239
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
PHASE3Active, not recruiting
705 participants
Started: Jul 22, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor210 locations
NCT05189925
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
PHASE1Recruiting
25 participants
Started: Jul 22, 2022 · Completed: Jul 1, 2026
2 conditions1 sponsor1 location
NCT05063240
Mobile Phone Text Messaging Plus Motivational Interviewing: Effects on Breastfeeding, Child Health Outcomes
NAActive, not recruiting
275 participants
Started: Jul 22, 2022 · Completed: Sep 30, 2024
2 conditions3 sponsors1 location
NCT04726059
Motor & Autonomic Concomitant Health Improvements With Neuromodulation & Exercise Training: An SCI RCT
NARecruiting
12 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT05476523
Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures
N/ARecruiting
2,000 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05450705
V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071)
PHASE3Active, not recruiting
1,500 participants
Started: Jul 22, 2022 · Completed: Aug 3, 2029
1 condition1 sponsor2 locations
NCT05419375
Screening Study for Participants With Malignant Tumors
PHASE2Recruiting
15,000 participants
Started: Jul 22, 2022 · Completed: Dec 22, 2032
1 condition1 sponsor162 locations
NCT03962465
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL
PHASE1Active, not recruiting
36 participants
Started: Jul 22, 2022 · Completed: Jul 31, 2026
1 condition5 sponsors4 locations
NCT05800951
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
N/AEnrolling by invitation
120 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2025
9 conditions2 sponsors17 locations
NCT05440617
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
N/ARecruiting
100 participants
Started: Jul 22, 2022 · Completed: Sep 21, 2041
3 conditions1 sponsor1 location
NCT05242471
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
PHASE2Active, not recruiting
703 participants
Started: Jul 22, 2022 · Completed: Nov 5, 2029
1 condition1 sponsor455 locations
NCT06706596
A Systemic Screening for TB Disease in High-risk Groups in Barcelona
N/ARecruiting
3,000 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2026
2 conditions9 sponsors1 location
NCT05412823
Neurologic Function Post Intubation
N/ARecruiting
1,000 participants
Started: Jul 22, 2022 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT07052539
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
N/ARecruiting
60 participants
Started: Jul 22, 2022 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT05250180
Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.
NARecruiting
90 participants
Started: Jul 22, 2022 · Completed: Jun 30, 2026
1 condition4 sponsors1 location
NCT05425303
System Dynamics Model for Acute Non-contact Lower Extremity Injuries Prediction
N/AActive, not recruiting
99 participants
Started: Jul 22, 2022 · Completed: Jul 31, 2025
4 conditions1 sponsor1 location
NCT05763277
Ate-Bev Early Response Prediction Model in Advanced HCC
N/ARecruiting
170 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05468736
Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years
PHASE2/PHASE3Active, not recruiting
3,600 participants
Started: Jul 22, 2022 · Completed: Oct 25, 2025
1 condition1 sponsor94 locations
NCT04404387
Lessening Organ Dysfunction With VITamin C in Septic ARDS
PHASE3Recruiting
800 participants
Started: Jul 22, 2022 · Completed: Jul 31, 2024
2 conditions1 sponsor1 location
NCT06469398
A Post Market Device Study for the Treatment of Acne
NAActive, not recruiting
50 participants
Started: Jul 21, 2022 · Completed: Aug 18, 2025
1 condition1 sponsor3 locations
NCT05724264
SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)
NARecruiting
1,000 participants
Started: Jul 21, 2022 · Completed: Dec 31, 2029
1 condition8 sponsors3 locations
NCT05295368
Strategies for Kidney Outcomes Prevention and Evaluation - The SKOPE Study
NARecruiting
896 participants
Started: Jul 21, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05522192
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
70 participants
Started: Jul 21, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05225714
Dermal Wound Closure Using Silkam®
N/ARecruiting
164 participants
Started: Jul 21, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05325645
Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
PHASE3Recruiting
450 participants
Started: Jul 21, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05032040
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
PHASE2Active, not recruiting
170 participants
Started: Jul 21, 2022 · Completed: Dec 30, 2025
5 conditions2 sponsors17 locations
NCT05358431
Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging Biomarkers
NARecruiting
120 participants
Started: Jul 21, 2022 · Completed: Feb 21, 2026
1 condition1 sponsor1 location
NCT04886531
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
PHASE2Recruiting
30 participants
Started: Jul 21, 2022 · Completed: Jan 31, 2026
4 conditions3 sponsors4 locations
NCT05067348
Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
PHASE2Recruiting
64 participants
Started: Jul 21, 2022 · Completed: Mar 30, 2026
1 condition1 sponsor6 locations
NCT05496686
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
PHASE1Recruiting
16 participants
Started: Jul 21, 2022 · Completed: Feb 25, 2029
2 conditions2 sponsors1 location
NCT05371613
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
PHASE2/PHASE3Recruiting
63 participants
Started: Jul 21, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor32 locations
NCT05453799
Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer
PHASE2Active, not recruiting
54 participants
Started: Jul 21, 2022 · Completed: Jul 15, 2027
3 conditions2 sponsors2 locations